Invention Application
- Patent Title: Polyomavirus Neutralizing Antibodies
-
Application No.: US17502910Application Date: 2021-10-15
-
Publication No.: US20220363735A1Publication Date: 2022-11-17
- Inventor: Johanna ABEND , Zorica DRAGIC , Adam Lloyd FEIRE , Mark KNAPP , Steven KOVACS , Elisabetta TRAGGIAI , Lichun WANG , Yongqiang WANG , Danqing WU , Qilong WU , Fangmin Xu
- Applicant: Novartis AG
- Applicant Address: CH Basel
- Assignee: Novartis AG
- Current Assignee: Novartis AG
- Current Assignee Address: CH Basel
- Priority: CNPCT/CN2015/089764 20150916
- Main IPC: C07K16/08
- IPC: C07K16/08 ; A61K39/42 ; A61K45/06 ; A61K9/19
Abstract:
The present invention relates to anti-VP 1 antibodies, antibody fragments, and their uses for the prevention and treatment of polyoma virus infection and associated diseases.
Public/Granted literature
- US11639378B2 Polyomavirus neutralizing antibodies Public/Granted day:2023-05-02
Information query
